Are you Dr. Goodman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 40 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 Medical 365 530 420 120 Plz
# 214
Los Angeles, CA 90095Phone+1 310-825-0631Fax+1 310-301-8751
Summary
- Dr. William Goodman, MD is a nephrologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is a Professor at UCLA School of Medicine.
Education & Training
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1974 - 1977- Henry Ford Health/Henry Ford HospitalInternship, Transitional Year, 1973 - 1974
Ohio State University College of MedicineClass of 1973
Certifications & Licensure
CA State Medical License 1979 - 2017
Publications & Presentations
PubMed
- 56 citationsThe Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) TrialPatrick S. Parfrey, Tilman B. Drüeke, Geoffrey A. Block, Ricardo Correa-Rotter, Jürgen Floege
Clinical Journal of the American Society of Nephrology. 2015-05-07 - 220 citationsThe Calcimimetic Agent AMG 073 Lowers Plasma Parathyroid Hormone Levels in Hemodialysis Patients with Secondary HyperparathyroidismWilliam G. Goodman, Gerald A. Hladik, Stewart A. Turner, Peter W. Blaisdell, David A. Goodkin
Journal of the American Society of Nephrology. 2002-04-01 - 5 citationsActivation of the Calcium Receptor by Calcimimetic Agents is Preserved Despite Modest Attenuating Effects of HyperphosphatemiaWilliam G. Goodman, Donald T. Ward, Kevin J. Martin, Debra Drayer, Carol Moore
Journal of the American Society of Nephrology. 2021-11-03
Grant Support
- Coronary Calcification In Hemodialysis PatientsNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2005
- Single &Multiple Doses Of An Oral Calcimimetic Agent In HyperparathyroidismNational Center For Research Resources1999–2001
- Diurnal And Pulsatile PTH Secretion In Renal FailureNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2001
- Diurnal And Secretion By The Parathyroid Glands In Chronic Renal InsufficiencyNational Center For Research Resources1998–2001
- R 568 In Hyperparathyroidism And END Stage Renal Disease Treated W/ HemodialysisNational Center For Research Resources1998–1999
- Bone Formation And Mineralization: Studies On AluminumNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1987–1988
- Bone Formation And Mineralization--Aluminum StudiesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1986
